BioCentury
ARTICLE | Company News

BioStratum in formulation deal with Shire

November 29, 2000 8:00 AM UTC

Shire Laboratories, a subsidiary of Shire Pharmaceuticals (LSE:SHP; SHPGY), will use its drug delivery technologies to develop an extended release formulation of Pyridorin, an advanced glycation end p...